ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RBCL RBC Life Sciences Inc (CE)

0.000067
0.00 (0.00%)
17 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
RBC Life Sciences Inc (CE) USOTC:RBCL OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000067 0.00 01:00:00

Post-effective Amendment to an S-8 Filing (s-8 Pos)

12/02/2016 8:44pm

Edgar (US Regulatory)




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
POST-EFFECTIVE AMENDMENT NO. 1
to
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
 
 
RBC LIFE SCIENCES, INC.
(Exact name of registrant as specified in its charter)
 
 
 
 
 
 
Nevada
 
2301 Crown Court
Irving, Texas 75038
 
91-2015186
(State or other jurisdiction of
incorporation or organization)
 
(Address, including zip code, of Principal Executive Offices)
 
(I.R.S. Employer
Identification No.)

RBC LIFE SCIENCES, INC.
2006 STOCK INCENTIVE PLAN
(Full title of the plan)
 
 
Steven E. Brown
President
RBC Life Sciences, Inc.
2301 Crown Court
Irving, Texas 75038
(Name, address, and telephone number, including area code, of agent for service)
 


DEREGISTRATION OF UNSOLD SECURITIES
This Post-Effective Amendment No. 1 relates to the Registration Statement on Form S-8 (Registration No. 333-139606), pertaining to 2,213,010 shares of common stock, par value $0.001 per share (“Common Stock”), of RBC Life Sciences, Inc. (the “Company”), issuable under the RBC Life Sciences, Inc. 2006 Stock Incentive Plan, which was filed with the Securities and Exchange Commission on December 22, 2006 (the “Registration Statement”).
The Company intends to terminate and suspend all reporting obligations with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. Accordingly, pursuant to the undertaking contained in the Registration Statement to remove from registration by means of a post-effective amendment any of the securities that remain unsold at the termination of the offering, the Registrant hereby amends the Registration Statement by removing and withdrawing from registration all shares that remain unsold under such Registration Statement.







SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Irving, State of Texas, on February 12, 2016.
RBC Life Sciences, Inc.
 
By: /s/ Steven E. Brown
Name: Steven E. Brown
Title: Chief Executive Officer
 



1 Year RBC Life Sciences (CE) Chart

1 Year RBC Life Sciences (CE) Chart

1 Month RBC Life Sciences (CE) Chart

1 Month RBC Life Sciences (CE) Chart

Your Recent History

Delayed Upgrade Clock